Previous Advocacy Updates

CAP calls for stronger health care cybersecurity standards; Make your voice heard in Washington, register for HOD/PLS; WV genetic privacy bill deterred in committee; CDC warns of rising measles cases.

Laboratory-developed tests FAQs; why pathologists need to advocate for the profession; sweeping changes at the Department of Health and Human Services.

A US District Court judge today nullified the FDA regulation on the oversight of laboratory-developed tests (LDT), agreeing with plaintiffs' and the CAP's arguments that the rule should be vacated; unlock your leadership potential with an exclusive workshop held on the first day of the House of Delegates and Pathologists Leadership Summit.

A US District Court judge today nullified the FDA regulation on the oversight of laboratory-developed tests (LDT), agreeing with plaintiffs' and the CAP's arguments that the rule should be vacated. 

Four key policy issues will top the list of priorities that the CAP will raise when members go to Capitol Hill on April 29; MedPAC says Medicare physician pay should account for inflation; CAP advocates for pathologists in federal AI action plan; it's time to Back the PAC!

Congress averted a government shutdown on March 14, but neglected to stop cuts to Medicare physician payment rates in 2025; the CAP expressed support for draft guidance by the Food and Drug Administration (FDA) on validating in vitro diagnostics (IVDs) for emerging pathogens during emergencies; multiple confirmation hearings and meetings are happening on Capitol Hill.

Register now for the Spring HOD, Pathologists Leadership Summit; House budget bill fails to stop Medicare cuts; CDC issues new health advisory on measles.

Pathologists send 1,400 messages to Congress to stop Medicare cuts; Conrad 30 bill reintroduced to address physician shortages; HHS to end notice-and-comment rulemaking for certain announcements.

The CAP urges HHS to heed executive order and revoke FDA LDT regulation; new House bill would stop funding for FDA LDT oversight; act now: reverse Medicare cuts.

Attorneys for the American Clinical Laboratory Association (ACLA) and Association for Molecular Pathology (AMP) had filed a motion to hold Wednesday’s hearing due to the first stage of the LDT regulation’s implementation on May 6.

Pathologists lobby to stop 2025 Medicare cuts; oral arguments for LDT lawsuit happening on February 19; navigating a changing political landscape for pathology.

Upcoming action alert to stop Medicare cuts; Arizona pathologists and the CAP fight to amend forensic autopsy legislation; register for HOD/PLS 2025.

The CAP is actively working with lawmakers to enact short- and long-term Medicare payment reforms; CAP President Donald Karcher, MD, FCAP, shares why pathologists should attend the annual summit; and, the CAP is engaging with CMS to influence the composition of a Pathology MVP to ensure it is meaningful for pathologists.

A motion has been granted in a US District Court in Eastern Texas to hear oral arguments over the federal oversight of laboratory-developed tests (LDTs) on February 19; the CAP is tracking President Trump's latest executive orders; registration is open for the CAP House of Delegates & Pathologists Leadership Summit 2025.

The USCDI+ Cancer Registry Version 1 (January 2025) Minimum Data Element List has been updated by the Department of Health and Human Services (HHS) to include CAP Cancer Protocols.

The CAP strongly supports the lawsuit filed by the California Society of Pathologists and Lincoln Luk, MD, FCAP against L.A. Care Health Plan in California Superior Court. This lawsuit seeks to revise L.A. Care Health Plan policy and compensate pathologists for the professional component of clinical pathology services.

On January 3, the 119th Congress kicked off the start of the next legislative session with leadership elections in the House. Over the next several weeks, the CAP will be monitoring upcoming congressional events and legislative changes that will impact pathologists and laboratories.

Throughout 2024, the College of American Pathologists (CAP) advocated on behalf of pathologists to address critical issues, including the oversight of laboratory-developed tests (LDTs), protecting the value of pathology services, opposing private payer interference, and state-level regulation of health insurance.

Congress just released a 2025 spending plan that included relief from Medicare payment cuts to physician services. The CAP applauded the proposal and continues to press lawmakers to enact the relief ahead of an expected 2.5% cut to Medicare pay for pathology services effective on January 1, 2025.

The FDA published guidance for premarket submission of artificial intelligence/machine learning (AI/ML) medical software on December 3. The guidance details information manufacturers should include in an FDA premarket submission so that they can alter their AI/ML software over time without needing to complete another FDA marketing submission.